Search Results - L. Devizzi
- Showing 1 - 2 results of 2
-
1
254 | RITUXIMAB AND IBRUTINIB COMBINATION IN UNTREATED SMZL AND NMZL: LONG‐TERM OUTCOME AND THE IMPACT OF EARLY MINIMAL RESIDUAL DISEASE FROM THE IELSG47/MALIBU PHASE II STUDY by C. Thieblemont, C. Row, T. Lamy, R. Aucagne, M. Tani, M. Merli, M. Deodato, S. V. Usai, C. Minoia, C. Bommier, C. Fournier, F. Bijou, M. C. Pirosa, A. Anastasia, L. Devizzi, S. Luminari, L. Arcaini, S. Chevreux, R. Gressin, M. André, N. Ielmini, L. Bonomini, E. Zucca, M. Callanan, A. Conconi
Published 2025Get full text
Artículo Open Access -
2
52 | RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE IN UNTREATED EXTRANODAL MARGINAL ZONE LYMPHOMAS: FIRST ANALYSIS OF THE IELSG47/MALIBU PHASE II STUDY by C. Thieblemont, M. Tani, M. Brociner, M. Merli, M. Deodato, A. M. Frustaci, S. Luminari, L. Devizzi, F. Bijou, C. Bommier, A. Anastasia, A. J. M. Ferreri, L. Arcaini, C. Boccomini, L. Orsucci, P. Feugier, P. Sesques, M. Gomes da Silva, T. Lamy, C. Minoia, M. André, I. Del Giudice, R. Gressin, V. Cacheux, T. Zenz, C. De Ramon Ortiz, E. Gyan, G. Damaj, S. Chevreux, O. Casasnovas, U. Novak, L. Ysebaert, L. Fornecker, G. Gini, M. C. Pirosa, F. Zaja, S. V. Usai, N. Ielmini, L. Bonomini, E. Zucca, A. Conconi
Published 2025Get full text
Artículo Open Access